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The present study shows that alumina nanotopography aﬀects monocyte/macrophage behavior. Human mononuclear cells
cultured on alumina membranes with pore diameters of 20 and 200nm were evaluated in terms of cell adhesion, viability,
morphology, and release of proinﬂammatory cytokines. After 24 hours, cell adhesion was assessed by means of light microscopy
and cell viability by measuring LDH release. The inﬂammatoryresponse was evaluated by quantifying interleukin-1β and tumour
necrosisfactor-α. Finally,scanningelectron microscopywasusedtostudycellmorphology.Resultsshowedpronounceddiﬀerences
in cell number, morphology,and cytokine release depending on the nanoporosity.Few but highlyactivated cells were foundon the
200nm porous alumina, while relatively larger number of cells were found on the 20nm porous surface. However, despite their
largernumber, the cells adhering onthe 20nm surface exhibited reduced pro-inﬂammatoryactivity. The data ofthis paper implies
that nanotopography could be exploited for controlling the inﬂammatory response to implants.
1.Introduction
Materials intended for applications in humans, that is,
biomaterials in the form of medical devices and pros-
theses, trigger biological responses such as inﬂammation,
tissue repair, and regeneration when implanted into living
tissue [1–3]. The initial event after implantation is the
adsorption of plasma proteins onto the material surface, a
complex procedure involving dynamic interactions between
the proteins and material surface, leading to conformational
changes of the proteins [4–7]. The subsequent phenomena,
that is, activation of the cascade systems of blood and
recruitment and adherence and activation of blood cells,
are governed by the initially adsorbed proteins [8, 9].
Platelets, neutrophils, and monocytes adhere to the plasma
protein-coatedbiomaterialsurface andbecomeplayersin the
activation of an inﬂammatory process. In particular, mon-
ocyte-derived macrophages play a key role in this immune
process. Upon activation, macrophages secrete cytokines,
chemokines, growth factors, and other bioactive agents that
modulate the function of both immune-competent and
tissue cells. Therefore, macrophages have a central role in the
tissue repair process, mediating the clearance of tissue debris
and bacteria and promoting wound healing through tissue-
cell migration and proliferation. In the case of implanted
materials, the presence of a layer of denaturated proteins is
likely to alter the activity of these cells leading to chronic
inﬂammation and tothe developmentofa ﬁbrotictissue that
preventsthe integration of the implant with the surrounding
tissue [1, 10].
Biologically inspired materials are being developed with
the aim of improving the integration of medical implants
and, as a consequence, their clinical performance [11].
Among the various biomimetic approaches, a promising
strategy is the design of topographically patterned surfaces
that resemble those found in the biological extracellular
environment of the tissues [12–14]. Indeed, a broad range
of cells (osteoblast, ﬁbroblasts, neutrophils, macrophages,2 International Journal of Biomaterials
endothelial, epithelial, and smooth muscle cells) have been
shown to react to nanoscale features in terms of cell adhe-
sion, morphology, orientation, and activity. These features
included grooves, ridges, spikes, islands, wells, nodes, and
pores [12, 15–19].
Nanoporous alumina has been recognized as an impor-
tant material and as a template for the fabrication of nanos-
tructures [20]. Anodic oxidation of aluminium in polyprotic
acids produces a well-ordered structure of nanoporous
alumina, where pore size can be determined by varying
the applied voltage [21]. Previous works have shown that
nanoporous alumina has a great inﬂuence on both com-
plement activation and platelet adhesion and activation
[22–24].
In this paper, the eﬀect of nanopore size on human
monocytes/macrophages (MM) in terms of cell adhesion,
morphology, and release of proinﬂammatory cytokines is
described. Alumina membranes with two distinct pore sizes
(i.e., 20nm and 200nm in diameter) were compared for
their ability to activate human MM. Alumina membranes
were treated with human plasma to induce the formation
of an adsorbed protein bioﬁlm and then incubated for 24
hours with freshly isolated human MM. Scanning electron
microscopy was used to evaluate the morphology of the
adhering cells. Levels of cell adhesion and viability were
quantitatively evaluated by means of light microscopy and
by measuring lactate dehydrogenase (LDH) activity in the
supernatants. Finally, cell activation was also assessed by
quantifying the release of proinﬂammatory cytokines such as
interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-
α).
2.Materialsand Methods
2.1.NanoporousAlumina. Nanoporousaluminamembranes
with pore diameters of 20 and 200nm (Anodisc Whatman
International Ltd, Madison, England) were used in this
study. The membrane discs were 13mm in diameter and
60μm thick with narrow pore size distribution. According
to Karlsson et al. [19], the membranes have similar surface
roughness and surface chemical characteristics independent
of porosity. Readers are referred to the work done by
Karlsson et al. [19] for detailed chemical compositions
of the nanoporous alumina membranes. Figure 1 shows
representative SEM micrographs of the surfaces of 20 and
200nm alumina membranes.
2.2. Isolation and Culture of Mononuclear Cells. Whole
venousbloodwasfreshlycollectedfromsevenhealthydonors
in heparin-coated 50mL Falcon tubes (Becton Dickinson,
USA)containing solubleheparin(LeoPharma A/S,Ballerup,
Denmark), giving a ﬁnal concentration of 1IU heparin/mL.
Human monocyte enrichment cocktail (RosetteSep, Stem-
Cell Technologies, Vancouver, BC, Canada) was added to
the heparinized blood according to the manufacturer’s
instructions. After 20 min of incubation, mononuclear
cells were isolated using Ficoll-paque medium (Amersham
Biosciences AB, Uppsala, Sweden). Brieﬂy, blood samples
containing the enrichment cocktailwere layered on to Ficoll-
paque medium and then centrifuged for 20 min at 1200×g
at room temperature. The mononuclear cell ring formed
at the plasma-Ficoll interface was collected and washed
three times with Hank’s balanced salt solution (HBSS,
Invitrogen, UK), containing 2% (v/v) foetal calf serum
(FCS).Cellswereﬁnally resuspendedinRPMI-1640medium
(Sigma, UK), supplemented with 5% (v/v) FCS, 100IU
penicillin/mL, and 100μg streptomycin/mL, and counted
using a haemocytometer. Cell viability was assessed using
trypan blue staining (95% cell viability). The cell isolation
step provided a fraction of platelet rich plasma (PRP) which
was collected and used for coating the materials. Alumina
membranes were placed in 24-well tissue culture plates and
coated with 1mL of PRP for 30min at 37◦C, followed by 3
washing steps with HBSS. Cells were added to the wells (4 ×
105 cells/well) and cultured for 24h at 37◦C, 5% CO2 in a
humidiﬁedatmosphere.After3hofincubation,mediumwas
changed to remove nonadherent lymphocytes. At the end of
each experiment, supernatants were collected, centrifuged,
aliquoted, and stored at −70◦C for future analyses. The
nanoporous alumina membranes were ﬁxed with 1.5% (v/v)
glutaraldehyde and stored at 4◦C until microscopy analyses.
2.3.Cell Number: Light Microscopy. Adherent cells were ﬁxed
with 1.5% (v/v) glutaraldehyde, stained with crystal violet,
and observed under a light microscope (Carl Zeiss, Jena
Germany). The density of adherent MM was determined
by counting cells in 9 representative 20x objective ﬁelds
(on duplicate samples) and expressed as number of MM
(± standard error) per membrane (n = 7).
2.4. Cell Viability: LDH Release. Nonviable cells were esti-
mated by analyzing the activity of lactate dehydrogenase
(LDH) in the culture medium. Duplicate samples of culture
medium were analyzed with a LDH activity kit (In vitro
toxicology assay kit LDH based, Sigma, Missouri, USA).
The assay measures LDH activity via the reduction of NAD.
The resulting reduced product (NADH) is used in the
stoichiometric conversion of a tetrazolium dye, and the
resulting coloured compound is measured spectrophoto-
metrically. The enzyme activity was measured by reading
the absorbance at 492nm and corrected by the values of
the blank (RPMI medium supplemented with 5% (v/v)
FCS, 100IU penicillin/mL, and 100μgs t r e p t o m y c i n / m L ) .A
negative control was done by measuring LDH activity of
cells cultured on Thermanox (Thermanox Coverslips, Nalge
NUNC International, Rochester, USA). Cultured cells lysed
by Triton-X100 served as positive control. LDH release was
expressed as arbitrary units (optical density at 492nm) and
normalized by the number of adherent cells. Values were
given as mean ± standard error of the normalized LDH
release from n = 7.
2.5. Cytokine Release: IL-1β and TNF-α. Cytokine produc-
tion was quantiﬁed in duplicate samples of supernatant by
enzymatic immunoassays. TNF-α and IL-1β were assayedInternational Journal of Biomaterials 3
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Figure 1: SEM micrographs showing nanoporous alumina membranes with pore diameters of 200nm (a) and 20nm (b).
by ELISA kits (Human IL-1β/IL-1F2 and Human TNF-
α/TNFSF1A Quantikine HS, R&D systems, UK) following
the manufacturer’s protocol. Cytokine values were obtained
as pg/mL and then normalized by the number of cells
adhering on the corresponding membrane. Values were
expressed as mean ± standard error from n = 7.The number
of nonadherent cells was negligible, and their production of
cytokines was assumed to be below the kit sensitivity.
2.6. Cell Morphology: Scanning Electron Microscopy. After
culture, the alumina membranes were ﬁxed with 1.5%
(v/v) glutaraldehyde, dehydrated through a series of acetone
concentrations (25, 50, 70, 80, 90, and 100% by volume),
and critically point dried and sputtered with gold, ﬁnally to
be studied using an LEO 1530, Gemini SEM. The degrees of
plasmalemma roughness and cell spreading were evaluated
as indicators of cell activation.
2.7. Statistics. Data were statistically evaluated by the Stu-
dent’st-testforunpairedsamples,usingStatviewsoftwarefor
Macintosh. Samples were considered statistically diﬀerent at
either P<. 001 or P<. 05.
3.Results
3.1. Cell Number. Nanoporous alumina membranes dis-
playedporesize-dependent monocyte/macrophageadhesion.
Examination of the nanoporous surfaces after 24h under
light microscopy showed that MM adhesion on the 20nm-
pore alumina membranes was signiﬁcantly higher than on
the 200nm-pore membranes (Figure 2). This increase was
signiﬁcantly diﬀerent and approximately 100% higher.
3.2.CellViability. MeasurementofreleasedLDHnormalized
by the number of adherent cells indicated no signiﬁcant
diﬀerence between the studied materials: 20nm (4 ± 1)
10−4 AU/cellnumber, 200nm(10 ± 2) 10−4 AU/cell number,
P>. 05. Comparison with the negative control indicated
similar cell viability: Thermanox (3 ± 1)10−4 AU/cell
number, P>. 05.CellslysedbyTriton-X100showed10times
higher values of normalized LDH release (P<. 05). Hence,
the studied material showed no signiﬁcant toxicity, and
cell viability was comparable with a commonly used tissue
culture substrate (Thermanox).
3.3. Cytokine Release. Comparison of IL-1β secreted by
cells attached to the diﬀerent materials showed that mono-
cytes/macrophages on the 200nm alumina surface secreted
signiﬁcantly higher levels of IL-1β than the cells attached
to the 20nm alumina membrane (Figure 3(a)). TNF-α
secretion showed the same tendency (Figure 3(b)).
3.4. Scanning Electron Microscopy. SEM micrographs show
that cell morphology is aﬀected by the diﬀerent surfaces
(Figures 4(a)–4(d)). The 20nm-pore alumina membranes
induced lower degree of cell spreading (Figures 4(a) and
4(c)) as MM appeared round-shaped and less spread than
the cells adhering on the 200nm-pore membranes (Figures
4(b) and 4(d)). The 200nm-pore surface presented cells
with rough plasmalemma and extensive ﬁlopodia, both
typical signs of activation (Figure 4(d)). Cells on the 20nm-
pore alumina, although showing some degree of membrane
ruﬄing, did not show well-established ﬁlipodia extensions,
thus indicating a lower degree of activation (Figure 4(c)).
Furthermore,thecellscontactingthistypeofporousalumina
seem to form clusters and fuse into giant cells (Figure 4(c)).
Conversely, the relatively fewer cells observed on the surface
of the 200nm-pore alumina were mostly adhering as single
and well-spread cells with only a few cell aggregates being
visible (Figure 4(d)). SEM studies also conﬁrmed higher cell
adhesion on20nm-pore alumina ascompared tothe200nm
membrane (Figures 4(a) and 4(b)).
4.Discussion
The recent advance in engineering nanosize materials has
shown the potential of controlling cell behavior and tis-
sue/implant integration by nanotopography [12, 14, 25].
Previousworkshavedemonstratedthatnanoporousalumina
c a nh a v ea ne ﬀect on neutrophil activation, complement4 International Journal of Biomaterials
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Figure 2: Representative light microscopy images of crystal violet-stained MM on (a) 20nm-pore alumina and (b) 200nm-pore alumina.
(c) Number of MM on alumina membranes determined by means of light microscopy. Cells were counted in 9 representative 20x objective
ﬁelds on each membrane. Data represents the mean ± SE from experiments using blood from 7 diﬀerent donors. Cell adhesion on the
20nm-pore alumina membrane was signiﬁcantlyhigher than on the 200nm-pore alumina (P<. 05).
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Figure 3: Cytokines released by MM after 24h of incubation with 20nm- and 200nm-pore alumina. Data represents the mean ± SE
from experiments using blood from 7 diﬀerent donors. A signiﬁcant diﬀerence between the two materials was observed for IL-1β release
(P<. 001), as well as a clear tendency for TNF-α.International Journal of Biomaterials 5
20μm
(a)
10μm
(b)
10μm
(c)
2μm
(d)
Figure 4: SEM micrographs of monocytes/macrophages after 24h of incubation on nanoporous alumina. MM on the 200nm-pore
membranes ((b) and (d)) show clear signs of activation (rough plasmalemma and extended ﬁlipodia), while cells on the 20nm-pore
membranes((a)and(c))appearmoreroundshapedwithlittlemembraneruﬄingandnoestablishedﬁlipodiaextensions.Ahighertendency
toward cell clustering and fusion was also observed on the 20nm-pore alumina (c).
activation, and platelet adhesion and activation [19, 22–24].
The eﬀect of the surface nanotopography of several bio-
materials on MM behavior has been widely described
[26–31]. Hence, with the intention of getting a more
complete understanding of the eﬀect of nanoporosity on
the inﬂammatory system we have chosen to evaluate the
response of MM to alumina membranes with diﬀerent
nanoporosities. The results of this work have shown that
the nanoporesize of the studied material aﬀects both MM
adhesion and activation. The diﬀerent activation states were
reﬂected by morphological changes and secretion levels of
proinﬂammatory cytokines.
A unique pattern of cell adhesion was observed on the
20nm-pore alumina, where the cells seem to prefer the
formation of clustering rather than spreading on the surface.
Clustering is the typical behavior of cells when in contact
with substrates unable to promote cell adhesion. In the
case of the 20-nm porous alumina substrates, cells showed
a tendency to form clustering, and they established only
limited connection with the substrate thus suggesting that
this material can limit monocytes/macrophages adhesion
and activation. The mild activation of these adhering MM
was conﬁrmed by the analysis of proinﬂammatory cytokines
TNF-α and IL-1β. Conversely MM adhering on the 200nm-
pore alumina membranes were able to establish a relatively
strong contact with the surface and were activated at levels
signiﬁcantly higher than MM adhering on the 20nm-pore
membranes.
The cytokine normalized data provides information
regarding the eﬀect of the diﬀerent nanoporosities on single
cells and indicates that 200nm pore size surface promotes
higher MM activation.
For a more clinically relevant approach, attention should
be paid to the total levels of cytokines. When evaluating
total levels of cytokines, higher levels of IL-1β were found
for MM culture on 200nm alumina compared with cells
on 20nm membranes: 20nm (10 ± 1.0) 103 pg/mL, 200nm
(13 ± 0.7) 103 pg/mL, P = .100. Although this diﬀerence
is not signiﬁcant, a tendency can be established, indicating
that 20nm alumina most probably will lead to a lower
overall inﬂammatory response as compared to the 200nm
membranes.
LDH activity was measured to determine if cytokine
release was caused by the loss of cell integrity as a con-
sequence of diﬀerent cytotoxic eﬀects by the biomaterials.
The lack of any signiﬁcant diﬀerence between the LDH
release of thecellsadhering onalumina-based surface and on
Thermanox suggested that the release of enzymatic activity
can be attributed to the degranulation process that the
cells are likely to undergo during their relative activation
by surface contact. Indeed, these levels were ten times
lower than those found in the positive controls, where cell
membrane integrity was deliberately disrupted by surfactant
treatment. These diﬀerences suggest lack of cytotoxicity by
the materials and corroborate the hypothesis of an active
release of cytokines by the activated cells.6 International Journal of Biomaterials
Two main mechanisms can be proposed to explain how
surface topography may aﬀect MM adhesion and activation.
Firstly, it is well established that material nanotopography
aﬀects protein adsorption, not only in terms of amount
but also in dictating conformational changes, orientation,
and exposure of cell-binding sites [7, 32]. Secondly, surface
topography has been found to aﬀect spreading, proliferation
and diﬀerentiation of cells [15, 25, 33]. It has been proposed
that cells are capable of sensing nanometric structures and
thereby of responding to these features by changing the
spatialorganization oftheircytoskeletonthroughmembrane
receptors. These variations are known to have an eﬀect on
gene expression and, as a consequence, on cell phenotype
and functions [25].
From the numerous studies thus far published it is
very diﬃcult to single out the eﬀects of adsorbed proteins
on MM adhesion and activation [34, 35]. In vitro studies
present a wide spectrum of materials, where chemistry and
topography have not always been varied in a systematic
and truly comparable manner. In addition, there is a great
variation in theuse of proteins as well as theirconcentrations
and the conditions for the adsorption processes [36–42].
There is a consensus about the role of ﬁbrinogen and C3
in promoting MM adhesion to biomaterial surfaces [43, 44].
However, the eﬀect of adsorbed proteins on cytokine release
varies between diﬀerent studies. For instance, Shen et al.
[39] describe that ﬁbrinogen adsorbed on several polymers
surfaces does not promote TNF-α release. The authors
propose that monocyte integrin receptors participate mostly
in cell adhesion, rather than directly activating MM for
cytokine release. On the contrary, Gretzer [45] describes a
ﬁbrinogen-mediated proinﬂammatory eﬀect with increased
monocytesecretionofIL-1βandTNF-αanddecreasedsecre-
tion of IL-10. Interactions of adsorbed IgG with monocyte
Fc receptors are also documented to promote the release of
IL-1β and TNF-α by adherent monocytes [46, 47]. Jenney
and Anderson[37] proposed that preadsorbed IgG promotes
long-term macrophage adhesion, an eﬀect that is mediated
by Fab and F(ab  )2 fragments instead of the Fc fragment.
A previous work has demonstrated that 200nm-pore
alumina adsorbed signiﬁcantly higher amounts of the
plasma proteins IgM, IgG, C3, and C1q than the 20nm-
pore membranes [24]. Thus, the results on MM adhesion
presented in this paper prove that not only the amount
of adsorbed protein but also the protein conformation
and orientation may play an important role for cellular
adhesion. Furthermore, MM could “sense” the topography
and as a result might expose diﬀerent membrane receptors
[25, 26]. Hence, the reduced number of adherent cells on
the 200nm-pore alumina could be related to changes in
protein conformation and/or MM “sensing” the diﬀerent
nanometric structure, thus leading to a less favorable
exposure of key binding receptors. Instead, MM seem to
adopt a conﬁguration favorable for exposure of activation
receptor-binding sites (e.g., receptors for Fc), and as a result,
they become highly activated, thus producing high levels of
cytokines.
Concerning the increased cell attachment on the 20nm-
pore alumina, it may be speculated that in addition to MM
exposing adhesion receptor-binding sites, the cells express
receptors favouring giant cell formation. However, despite
the relatively higher cell number, the cytokine release on
this type of membrane is less pronounced than on the
200nm-pore membranes. Hence, as proposed by Young el
al. [47], it can be hypothesized that greater activation energy
is required to activate the receptors of MM attached to
the 20nm-pore surface as compared to the 200nm-pore
alumina.
C5a and C3a are anaphylatoxins generated when the
complement systems are activated. C5a stimulates the release
of inﬂammatory cytokines by MM [48]. C3a has also
been described to enhance TNF-α and IL-1β synthesis by
adherent monocytes [49]. As blood exposure to 200nm-
pore alumina leads to much higher complement activation
than when exposed to the 20nm-pore membranes [24], the
increased levels of C5a and C3a could also contribute to
the diﬀerence observed in cytokine secretion between the
membranes. Themechanisms thatregulatematerial-induced
MM activation are not yet completely understood. However,
in the case of nanoporous alumina, a direct relationship
between complement activation and MM cytokine release
can be postulated.
The present work shows that by changing the nanopore
size of alumina it is possible to modulate MM behavior. In
addition, this data opens the possibility of exploiting some
of the beneﬁcial functions of macrophages in promoting
tissue repair rather than chronic inﬂammation. Additional
studies to determine the fate of the cells over longer period
of time as well as the secretion of other growth factors are
needed for further understanding of the eﬀect of surface
nanotopography on MM.
5.Conclusions
The present study shows that alumina nanotopography
aﬀects MM behavior. We found a clear diﬀerence in cell
adhesion and activation between alumina membranes with
20nm pores as compared to membranes with 200nm
pores. Few but highly activated cells adhered to the 200nm
membrane in contrast to many but less activated MM on the
20nm surface. Regardless of the speciﬁc clinical applications
of these types of surfaces, the data of this paper emphasizes
the role of material nanotexture in dictating inﬂammatory
cell responses and implies that nanotopography can be
exploited to subtly control the inﬂammatory potential of
medical implants.
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